Does LEUPROLIDE Cause Incorrect product storage? 44 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Incorrect product storage have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.1% of all adverse event reports for LEUPROLIDE.
44
Reports of Incorrect product storage with LEUPROLIDE
0.1%
of all LEUPROLIDE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Incorrect product storage From LEUPROLIDE?
Of the 44 reports, 1 (2.3%) required hospitalization.
Is Incorrect product storage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Incorrect product storage?
ETANERCEPT (2,149)
INSULIN LISPRO (1,114)
ABATACEPT (583)
TERIPARATIDE (573)
ADALIMUMAB (476)
GOLIMUMAB (392)
INSULIN GLARGINE (341)
INSULIN HUMAN (336)
USTEKINUMAB (299)
ERYTHROPOIETIN (268)
Which LEUPROLIDE Alternatives Have Lower Incorrect product storage Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM